WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+3.29%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$4.51B
AUM Growth
+$4.51B
(+20%)
Cap. Flow
+$726M
Cap. Flow
% of AUM
16.11%
Top 10 Holdings %
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74
Top Buys
| 1 |
Gilead Sciences
GILD
|
$99.7M |
| 2 |
Johnson & Johnson
JNJ
|
$79M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$78.4M |
| 4 |
Electronic Arts
EA
|
$60.5M |
| 5 |
Danaher
DHR
|
$59.2M |
Top Sells
| 1 |
Amgen
AMGN
|
$104M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$97.8M |
| 3 |
Medtronic
MDT
|
$68.7M |
| 4 |
Applied Materials
AMAT
|
$67.9M |
| 5 |
NXP Semiconductors
NXPI
|
$61.6M |
Sector Composition
| 1 | Healthcare | 47.83% |
| 2 | Technology | 26.5% |
| 3 | Communication Services | 6.68% |
| 4 | Consumer Discretionary | 4.05% |
| 5 | Financials | 2.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Affirm
AFRM
$27.8B
| $11.3M | 0.25% |
+159,568
| New | +$11.3M |
|
|
DISH
102
DELISTED
DISH Network Corp.
DISH
| $11.2M | 0.25% |
309,484
+93,481
| +43% | +$3.38M |
|
|
TRIL
103
DELISTED
Trillium Therapeutics Inc.
TRIL
| $11.1M | 0.25% |
1,034,991
+273,526
| +36% | +$2.94M |
|
|
JNPR
104
DELISTED
Juniper Networks
JNPR
| $11.1M | 0.25% |
+437,327
| New | +$11.1M |
|
105
Knowles
KN
$1.8B
| $10.9M | 0.24% |
522,165
-200,814
| -28% | -$4.2M |
|
106
Corcept Therapeutics
CORT
$7.52B
| $10.9M | 0.24% |
458,501
-107,391
| -19% | -$2.55M |
|
|
NAPA
107
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $10.9M | 0.24% |
+647,735
| New | +$10.9M |
|
108
Ericsson
ERIC
$26.2B
| $10.8M | 0.24% |
818,237
-71,037
| -8% | -$937K |
|
109
Airbnb
ABNB
$76.5B
| $10.8M | 0.24% |
57,309
+7,309
| +15% | +$1.37M |
|
110
Interpublic Group of Companies
IPG
$9.69B
| $10.8M | 0.24% |
368,801
+293,807
| +392% | +$8.58M |
|
111
Seer Inc
SEER
$114M
| $10.7M | 0.24% |
213,151
-12,381
| -5% | -$619K |
|
112
Zai Lab
ZLAB
$3.48B
| $10.5M | 0.23% |
78,902
+17,532
| +29% | +$2.34M |
|
|
HMCO
113
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $10.5M | 0.23% |
+1,055,321
| New | +$10.5M |
|
114
Fate Therapeutics
FATE
$115M
| $10.4M | 0.23% |
+126,360
| New | +$10.4M |
|
|
ABMD
115
DELISTED
Abiomed Inc
ABMD
| $10.2M | 0.23% |
+31,907
| New | +$10.2M |
|
116
Acadia Pharmaceuticals
ACAD
$4.34B
| $10.1M | 0.22% |
390,591
+339,678
| +667% | +$8.76M |
|
117
Baidu
BIDU
$33.1B
| $10.1M | 0.22% |
+46,239
| New | +$10.1M |
|
|
ITCI
118
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.99M | 0.22% |
294,285
-30,482
| -9% | -$1.03M |
|
119
Simply Good Foods
SMPL
$2.88B
| $9.94M | 0.22% |
326,820
-21,290
| -6% | -$648K |
|
120
McKesson
MCK
$85.9B
| $9.89M | 0.22% |
+50,708
| New | +$9.89M |
|
121
TD Synnex
SNX
$12.2B
| $9.75M | 0.22% |
+84,921
| New | +$9.75M |
|
122
Chewy
CHWY
$16.8B
| $9.55M | 0.21% |
112,704
+25,861
| +30% | +$2.19M |
|
123
Eledon Pharmaceuticals
ELDN
$155M
| $9.53M | 0.21% |
891,055
-1,500
| -0.2% | -$16.1K |
|
124
AnaptysBio
ANAB
$630M
| $9.24M | 0.21% |
+428,847
| New | +$9.24M |
|
125
Charles River Laboratories
CRL
$7.99B
| $9.2M | 0.2% |
31,736
+5,533
| +21% | +$1.6M |
|